Glickman Mark A Insider Trades

Insider Trading History

Track insider trading activity for Glickman Mark A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
NeuroBo Pharmaceuticals
NeuroBo Pharmaceuticals NRBO
Director
Holding Value $23k 9,740 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.7k 5,051 shares
$3.91
$2.36
TherapeuticsMD
TherapeuticsMD TXMD
Co-chief Executive Officer
Holding Value $2.55k 1,294 shares
Last Trade
Dec 06, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.16k 440 shares
$4.92
$1.97
TherapeuticsMD
TherapeuticsMD TXMD
Co-chief Executive Officer
Holding Value $6.83k 3,466 shares
Last Trade
Dec 06, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.36k 1,734 shares
$5.40
$1.97
TherapeuticsMD
TherapeuticsMD TXMD
Co-chief Executive Officer
Holding Value $3.42k 1,734 shares
Last Trade
Dec 06, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$9.36k 1,734 shares
$5.40
$1.97
TherapeuticsMD
TherapeuticsMD TXMD
Chief Business Officer
Holding Value $512k 260,000 shares
Last Trade
Mar 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.94M 260,000 shares
$19.00
$1.97
TherapeuticsMD
TherapeuticsMD TXMD
Chief Business Officer
Holding Value $512k 260,000 shares
Last Trade
Mar 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.66M 260,000 shares
$21.78
$1.97
TherapeuticsMD
TherapeuticsMD TXMD
Chief Business Officer
Holding Value $788k 400,000 shares
Last Trade
Oct 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$33.2M 920,000 shares
$36.04
$1.97
Esperion Therapeutics
Esperion Therapeutics ESPR
Chief Commercial Officer
Holding Value $83.6k 26,625 shares
Last Trade
Jan 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2M 32,550 shares
$61.34
$3.14
Esperion Therapeutics
Esperion Therapeutics ESPR
Chief Commercial Officer
Holding Value $62.8k 20,000 shares
Last Trade
Dec 20, 2018 Sale
$6.94M 168,000 shares
$41.30
$3.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up